iBio (IBIO) Capital Leases (2016 - 2024)

iBio's (IBIO) quarterly Capital Leases came in at $53000.0 in Q2 2024, down 84.9% year-on-year from $351000.0 in Q3 2023, and down 59.23% on a QoQ basis from $130000.0 in Q1 2024.

iBio (IBIO) Capital Leases (2016 - 2024) Analysis & Trends

iBio (IBIO) has 9 years of Capital Leases data on file, last reported at $53000.0 in Q2 2024.

  • On a quarterly basis, Capital Leases fell 84.9% year-over-year to $53000.0 in Q2 2024; TTM through Jun 2024 was $53000.0, a 84.9% decrease from a year earlier, with the FY2024 full-year figure at $53000.0, down 84.9% from the prior year.
  • Capital Leases for Q2 2024 stood at $53000.0, down from $130000.0 in the prior quarter.
  • Over the last five years, Capital Leases for IBIO reached as high as $32.1 million in Q1 2020 and fell as low as $30000.0 in Q2 2022.
  • Historically, Capital Leases has averaged $12.5 million across 5 years, with a median of $456000.0 in 2022.
  • Across the five-year window, Capital Leases slumped 99.91% in 2022 and jumped 1070.0% in 2023, its largest moves.
  • Year by year, Capital Leases stood at $31.8 million in 2020, then tumbled by 99.84% to $51000.0 in 2021, then soared by 860.78% to $490000.0 in 2022, then sank by 58.16% to $205000.0 in 2023, then tumbled by 74.15% to $53000.0 in 2024.
  • Per Business Quant data, the three most recent Capital Leases figures were $53000.0 in Q2 2024, $130000.0 in Q1 2024, and $205000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 iBio 172.22 Mn 172.22 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 53,000.00
Mar 31, 2024 130,000.00
Dec 31, 2023 205,000.00
Sep 30, 2023 53,000.00
Jun 30, 2023 351,000.00
Mar 31, 2023 422,000.00
Dec 31, 2022 490,000.00
Sep 30, 2022 576,000.00
Jun 30, 2022 30,000.00
Mar 31, 2022 41,000.00
Dec 31, 2021 51,000.00
Sep 30, 2021 31.66 Mn
Jun 30, 2021 31.76 Mn
Mar 31, 2021 31.77 Mn
Dec 31, 2020 31.85 Mn
Sep 30, 2020 31.93 Mn
Jun 30, 2020 32.01 Mn
Mar 31, 2020 32.08 Mn
Mar 31, 2019 24.73 Mn
Dec 31, 2018 24.78 Mn